Tunn E - Search Results

1

Panniculitis, arthritis and pancreatitis.

Francombe J, Kingsnorth AN, Tunn E. Francombe J, et al. Among authors: tunn e. Br J Rheumatol. 1995 Jul;34(7):680-3. doi: 10.1093/rheumatology/34.7.680. Br J Rheumatol. 1995. PMID: 7670790

2

Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic.

Tunn EJ, Bacon PA. Tunn EJ, et al. Br J Rheumatol. 1993 Feb;32(2):97-103. doi: 10.1093/rheumatology/32.2.97. Br J Rheumatol. 1993. PMID: 8428243

3

Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized, placebo-controlled study.

Scott DL, Dawes PT, Tunn E, Fowler PD, Shadforth MF, Fisher J, Clarke S, Collins M, Jones P, Popert AJ, et al. Scott DL, et al. Among authors: tunn e. Br J Rheumatol. 1989 Apr;28(2):128-33. doi: 10.1093/rheumatology/28.2.128. Br J Rheumatol. 1989. PMID: 2650798 Clinical Trial.

4

Immunodeficiencies associated with sulphasalazine therapy in inflammatory arthritis.

Farr M, Kitas GD, Tunn EJ, Bacon PA. Farr M, et al. Among authors: tunn ej. Br J Rheumatol. 1991 Dec;30(6):413-7. doi: 10.1093/rheumatology/30.6.413. Br J Rheumatol. 1991. PMID: 1684124

5

Genetic factors influencing the outcome of early arthritis--the role of sulphoxidation status.

Emery P, Bradley H, Arthur V, Tunn E, Waring R. Emery P, et al. Among authors: tunn e. Br J Rheumatol. 1992 Jul;31(7):449-51. doi: 10.1093/rheumatology/31.7.449. Br J Rheumatol. 1992. PMID: 1628166

6

Sulphasalazine in rheumatoid arthritis: haematological problems and changes in haematological indices associated with therapy.

Farr M, Tunn EJ, Symmons DP, Scott DG, Bacon PA. Farr M, et al. Among authors: tunn ej. Br J Rheumatol. 1989 Apr;28(2):134-8. doi: 10.1093/rheumatology/28.2.134. Br J Rheumatol. 1989. PMID: 2565128

7

Association of Pharmacological Biomarkers with Treatment Response and Longterm Disability in Patients with Psoriatic Arthritis: Results from OUTPASS.

Jani M, Chinoy H, Barton A; for OUTPASS. Jani M, et al. J Rheumatol. 2020 Aug 1;47(8):1204-1208. doi: 10.3899/jrheum.190253. Epub 2019 Aug 1. J Rheumatol. 2020. PMID: 31371650

8

Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis.

Hum RM, Ho P, Nair N, Jani M, Morgan AW, Isaacs JD, Wilson AG, Hyrich KL, Plant D, Barton A; BRAGGSS Collaborators. Hum RM, et al. Rheumatology (Oxford). 2023 Jun 1;62(6):2090-2097. doi: 10.1093/rheumatology/keac564. Rheumatology (Oxford). 2023. PMID: 36190343 Free PMC article.

9

The association of HLA DR beta alleles with self-limiting and persistent forms of early symmetrical polyarthritis.

Salmon M, Wordsworth P, Emery P, Tunn E, Bacon PA, Bell JI. Salmon M, et al. Among authors: tunn e. Br J Rheumatol. 1993 Jul;32(7):628-30. doi: 10.1093/rheumatology/32.7.628. Br J Rheumatol. 1993. PMID: 8339139

10

The long term effects of sulphasalazine in the treatment of rheumatoid arthritis and a comparative study with penicillamine.

Farr M, Tunn E, Crockson AP, Bacon PA. Farr M, et al. Among authors: tunn e. Clin Rheumatol. 1984 Dec;3(4):473-81. doi: 10.1007/BF02031270. Clin Rheumatol. 1984. PMID: 6151882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters